Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 48: 1123-1126, 2002;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (26)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bökenkamp, A.
Right arrow Articles by Stoffel-Wagner, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bökenkamp, A.
Right arrow Articles by Stoffel-Wagner, B.
Related Collections
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 2002;48:1123-1126.)
© 2002 American Association for Clinical Chemistry, Inc.


Technical Briefs

Effect of Corticosteroid Therapy on Serum Cystatin C and ß2-Microglobulin Concentrations

Arend Bökenkamp1,2a, Joanna A.E. van Wijk2, Michael J. Lentze1 and Birgit Stoffel-Wagner3

1 Children’s Hospital, Medical Center of Bonn University, D-53113 Bonn, Germany;
2 Children’s Hospital, Vrije Universiteit Medical Center, NL-1007 MB Amsterdam, The Netherlands;
3 Department of Clinical Biochemistry, Medical Center of Bonn University, D-53105 Bonn, Germany

aaddress correspondence to this author at: Kindernefrologie, Vrije Universiteit Medisch Centrum, De Boelelaan 1117, NL-1007 MB Amsterdam, The Netherlands; fax 31-20-444-0849, e-mail bokenkamp@VUMC.nl

The first 20% of the full text of this article appears below.

Cystatin C, a cationic low-molecular-weight protein (Mr 13 300) (1), has been described as a promising endogenous marker of glomerular filtration rate (GFR) in both adults (2)(3) and children (4). The correlation of serum cystatin C concentrations with the results of inulin and 51Cr-EDTA clearance examinations was superior to the correlation obtained with serum creatinine (2)(3)(4). The gene for cystatin C is expressed in all nucleated cells (5) and bears the characteristics of a housekeeping gene (6). Therefore, the cystatin C production rate is assumed to remain constant (3). This is supported by clinical evidence from several studies (7)(8). In renal transplant recipients, however, increases in serum cystatin C concentrations out of proportion to renal function impairment have been reported (9)(10)(11)(12)(13). Although serum cystatin C decreases before serum creatinine falls after successful transplantation, serum cystatin C concentrations increase by almost 30% between days 2 and 6 despite stable allograft function (14)(15). The pathogenesis of this observation is as yet unexplained. Because patients receive high doses of corticosteroids after transplantation, a potential role of concomitant steroid therapy has been discussed (9)(12). In patients with severe asthma, Cimerman et al. (16) observed an increase in serum cystatin C with high-dose corticosteroid therapy. In vitro, dexamethasone produces a significant and dose-dependent increase in cystatin C production in HeLa cells (17).

To investigate the effect of systemic steroid . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
A. Bokenkamp, C. A.R.C. Laarman, K. I. Braam, J. A.E. van Wijk, W. A. Kors, M. Kool, J. de Valk, A. A. Bouman, M. D. Spreeuwenberg, and B. Stoffel-Wagner
Effect of Corticosteroid Therapy on Low-Molecular Weight Protein Markers of Kidney Function
Clin. Chem., December 1, 2007; 53(12): 2219 - 2221.
[Full Text] [PDF]


Home page
DiabetesHome page
D. M. Maahs, L. G. Ogden, A. Kretowski, J. K. Snell-Bergeon, G. L. Kinney, T. Berl, and M. Rewers
Serum Cystatin C Predicts Progression of Subclinical Coronary Atherosclerosis in Individuals With Type 1 Diabetes
Diabetes, November 1, 2007; 56(11): 2774 - 2779.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
M. Zaffanello, M. Franchini, and V. Fanos
Is Serum Cystatin-C a Suitable Marker of Renal Function in Children?
Ann. Clin. Lab. Sci., January 1, 2007; 37(3): 233 - 240.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
U. Poge, T. Gerhardt, A. Bokenkamp, B. Stoffel-Wagner, H.-U. Klehr, T. Sauerbruch, and R. P. Woitas
Time course of low molecular weight proteins in the early kidney transplantation period--influence of corticosteroids
Nephrol. Dial. Transplant., November 1, 2004; 19(11): 2858 - 2863.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Association for Clinical Chemistry.